The use of nanometer-sized iron oxide particles combined with molecular imaging techniques enables dynamic studies of homing and trafficking of human hematopoietic stem cells (HSC). Identifying clinically applicable strategies for loading nanoparticles into primitive HSC requires strictly defined culture conditions to maintain viability without inducing terminal differentiation. In the current study, fluorescent molecules were covalently linked to dextrancoated iron oxide nanoparticles (Feridex) to characterize human HSC labeling to monitor the engraftment process. Conjugating fluorophores to the dextran coat for fluorescence-activated cell sorting purification eliminated spurious signals from nonsequestered nanoparticle contaminants. A short-term defined incubation strategy was developed that allowed efficient labeling of both quiescent and cycling HSC, with no discernable toxicity in vitro or in vivo. Transplantation of purified primary human cord blood lineage-depleted and CD34
INTRODUCTION
Highly purified human hematopoietic stem cells (HSC) are identified functionally by performing in vivo repopulation studies in immune-deficient animals. Previous in vivo studies of human HSC homing and engraftment have been performed using genetic labels, radionuclides, or membrane dyes [1] . Although efficient, these techniques encompass a number of limitations. Genetic modification of cells with a reporter gene carries a low but real risk of permanently altering the phenotype or behavior of the target cell [2] . High doses of radionuclides or membrane dyes can also be toxic to cells. Researchers are therefore examining alternative methods to label HSC and track their migration in vivo, which were the goals of the current study.
Recently, long-term repopulating cells labeled with native or dextran-coated superparamagnetic iron oxide nanoparticles (SPIOs) have been tracked using magnetic resonance imaging (MRI) [3] [4] [5] [6] [7] [8] . SPIOs such as Feridex are inert, biocompatible nanoparticles that are eventually metabolized and enter into whole body iron metabolism pathways. Feridex (Bayer Healthcare, Cambridge, MA, http://imaging. bayerhealthcare.com/html/feridex/index.html) is approved as a contrast agent for imaging of the liver after i.v. infusion of the contrast agent, but it is not currently U.S. Food and Drug Administration (FDA)-approved for cell labeling or cell tracking. Because dextran-coated SPIOs have an inherent negative surface charge, they inefficiently label human stem cells and other mammalian cell types, with the exception of phagocytic cells, such as macrophages. To overcome this limitation, a number of approaches have been described to modify the dextran coating to facilitate uptake in specific cell populations. The primary labeling approach involves complexing polycationic transfection agents with SPIOs [9 -13] . Other examples include conjugating Tat peptides or cell-specific antibodies to the dextran coat to increase labeling efficiencies [7, 14 -17] .
Electrostatic interactions between polycationic materials and the dextran coat form stable complexes that can bind to the cell membrane and enter the cell through pinocytosis and/or endocytosis-mediated pathways. Of the polycationic transfection agents, protamine sulfate is particularly suited for in vivo studies because it is FDA-approved, currently used in clinical trials examining gene transduction by retroviral vectors, and exhibits a lower toxicity toward cells compared with other polycationic species [11] . Defining ex vivo cultivation strategies for the labeling of HSC populations with nanoparticles must involve the use of strictly defined in vitro culture conditions with the aim of maintaining target cell viability without inducing terminal differentiation or damaging the homing and engraftment potential of the target cells.
In the current study, two agents, Feridex and protamine sulfate, were used to label human HSC populations under defined, clinically applicable, serum-free ex vivo conditions for subsequent tracking. To assess the labeling efficiencies in cells with different phenotypes, as assessed by flow cytometry, redshifted Alexa Fluor dye molecules were covalently linked to the dextran coat of Feridex (Fe[647] ϩ CD34 ϩ cells transplanted into immunodeficient NOD/SCID ␤2M-null mice showed that labeled cells could be detected for up to 3 weeks. Fluorescence imaging and flow cytometry analysis of both the bone marrow and hematopoietic organs revealed the presence of Fe [750] ϩ CD34 ϩ cells. The current study provides a method by which investigators can track human stem cells to the marrow versus different tissues of immune-deficient mice. This has been extremely difficult in the past, because stem cells can alter their phenotype after engraftment. The fluorophore-tagged Feridex allows a clean recovery of labeled cells from different tissues by FACS for cell surface phenotype probing and other assays. Traditional staining methods with Prussian blue and antidextran fluorophores can show that cells are Feridex-positive but do not permit a quantitative determination of engraftment post-transplantation. Because of the fluorophore modification, quantitation of the number of cells that are engrafted in the bone marrow after transplantation is possible and allows simultaneous probing of cell surface phenotype using flow cytometry, without the requirement for isolating cells based on a predetermined cell surface marker. The use of fluorophore-labeled Feridex nanoparticles and the clinically relevant incubation procedure described in the current study offer an efficient and safe method to label both cycling and noncycling human hematopoietic stem and progenitor cells without toxicity and to evaluate the homing, localization, phenotype, and short-term engraftment capabilities of defined human HSC subsets.
MATERIALS AND METHODS

Cell Sources
Human umbilical cord blood (CB) samples were obtained from the cord blood banking facility at Cardinal Glennon Children's Hospital (St. Louis, MO). Human bone marrow (BM) samples were obtained from the Oncology Division at the Siteman Cancer Center (St. Louis, MO). Use of these samples was approved by the local ethical and biohazard authorities at Washington University School of Medicine (St. Louis, MO). Mononuclear cells (MNC) were isolated by gradient density centrifugation using Ficoll-Hypaque (Amersham Pharmacia Biotech Inc., Uppsala, Sweden, http://www.biobank.co. kr/maker/aaa/amersham.shtml). MNC from CB and BM were enriched for CD34 antigen-positive cells using a Miltenyi AutoMACS device in accordance with the specifications from the manufacturer (Miltenyi Biotec, Auburn, CA, http://www.miltenyibiotec.com). The purity of the CD34 ϩ cells was determined using singleparameter analysis on an FC500 flow cytometer (Beckman Coulter, Hialeah, FL, http://www.beckmancoulter.com) after labeling with a directly anti-human allophycocyanin (APC)-conjugated monoclonal antibody (MoAb) (CD34 class III-APC; Dako, Glostrup, Denmark, http://www.dako.com). The CD34 ϩ purity was in all cases Ͼ90%. Lin Ϫ preparations were isolated as previously described [18] . [15] . Briefly, 1 ml of Feridex (11.2 mg/ml) was added to a solution containing 1.6 ml of KOH, 0.7 ml of double-distilled H 2 O (ddH 2 O), and 0.7 ml of epichlorohydrin [19] . The mixture was reacted for 12 hours with constant shaking. To produce reactive amines on the dextran coat, concentrated ammonia (0.5 ml) was added to the Feridex and reacted overnight at 37°C. Excess epichlorohydrin and ammonia were removed by extensive dialysis against ddH 2 O using 12,000 -14,000 molecular weight cut off tubing. Feridex was reacted with 1 mg of Alexa Fluor 647 or 750 succinimidyl ester (Molecular Probes, Eugene, OR, http://probes. invitrogen.com) overnight at room temperature. Excess fluorophore was removed by centrifuging the sample at 160,000g for 30 minutes. The supernatant was discarded, and the pellet was resuspended in phosphate-buffered saline (PBS) buffer (pH 7.4). The centrifugation step was repeated four times to ensure that unconjugated fluorophore was removed from the sample. Removal of excess fluorophore was confirmed using a fluorometer. To disperse and remove large nanoparticle aggregates, the sample was sonicated for 5 minutes and filtered using a 0.2 M size-exclusion filter.
Preparation of
The iron concentration was measured using the method described by Stookey [20] . The number of fluorescent molecules was calculated by using a standard curve of known Alexa Fluor 750 concentration. From these measurements, assuming an average particle diameter of 80 nm, we determined that there were approximately 140 molecules per iron particle.
Labeling Protocol
Cell cultivation was carried out in 96-well tissue culture-treated plates coated with the recombinant fibronectin fragment CH-296 (25 g/cm 2 ) (RetroNectin; TaKaRa Shuzo, Kyoto, Japan, http:// www.transnationale.org/companies/takara_shuzo.php) as described [21] [22] [23] . X-Vivo 15 defined serum-free medium (BioWhittaker Inc., Walkersville, MD, http://www.devicelink.com/company/ivdt/b/ b0092.html) was supplemented with 10 ng/ml thrombopoietin, recombinant human stem cell factor (rhSCF), and . Cultured cells were harvested at specific time points using enzyme-free PBS-based cell dissociation buffer (Gibco, Grand Island, NY, http://www.invitrogen. com) to release cells from integrin-mediated adhesion to the CH-296-coated plates.
Clonogenic Progenitor Assay
Human clonogenic progenitor assays were performed by plating 1,000 cells from the ex vivo cultures into methylcellulose medium (Methocult H4434; StemCell Technologies, Vancouver, BC, Canada, http://www.stemcell.com) containing 50 ng/ml rhSCF, 10 ng/ml recombinant human granulocyte colony-stimulating factor, and 10 ng/ml recombinant human interleukin 3. Cells (1,000 cells per ml of medium per dish) were plated in gridded colony-forming unit (CFU) dishes. Colony-forming capacity was evaluated as described [24] by enumeration under light microscopy following 14 days incubation at 37°C, 5% CO 2 .
Transplantation
NOD/SCID microglobulin (〉2M)-null mice [25, 26] were obtained from the Jackson Laboratory (Bar Harbor, ME, http://www.jax.org). The studies were approved by the Animal Studies Committee at Washington University. Six-to 8-week-old mice were irradiated with 300 -350 cGy prior to transplantation. Mice were then transplanted by i. ϩ CD34 ϩ cells. Animals were sacrificed at defined time points between 24 hours and 8 weeks posttransplantation. Bones and spleen were collected from each mouse as described [27, 28] for subsequent analyses by flow cytometry and fluorescence imaging.
Flow Cytometry Analysis
Harvested cells were resuspended in PBS, and cellular Fc receptors were blocked by addition of purified rat anti-mouse CD16/CD32 (fc ␦ III/II receptor) MoAb (BD Pharmingen, San Diego, http://www. bdbiosciences.com/index_us.shtml). Forward and orthogonal light scattering were used to exclude debris and dead cells. For the extended analysis of the iron label in defined HSC subsets, as well as to assess engraftment in transplanted NOD/SCID ␤2M-null mice, multiparameter flow cytometry using directly conjugated humanspecific CD34 and CD45 MoAbs (DakoCytomation, Glostrup, Denmark, http://www.dakocytomation.com) was performed. The human CD133/2-PE MoAb was obtained from Miltenyi Biotec. Cells were analyzed on a Coulter FC500 flow cytometer (Beckman Coulter) using the software provided. FACS was performed using a custom-modified MoFlo sorter (DakoCytomation).
Fluorescence Imaging
Imaging was performed using a Kodak 4000MM multimodal imager (Kodak, Rochester, NY, http://www.kodak.com) equipped with an IS4000MM charge-coupled device camera. The instrument settings were as follows: focal plane, 13 mm; zoom, 60 mm; f-stop, open; x-ray acquisition time, 20 seconds; fluorescence acquisition time, 60 seconds; excitation filter, 750 wavelength (WA); emission filter, 800 WA; binning, 2 ϫ 2. Animals were imaged pre-and postinjection, at 24 hours, and at 1-week intervals up to 3 weeks. An x-ray image was acquired for 20 seconds prior to fluorescence image. The fluorescent images were acquired for each cohort of animals using the setting described in Materials and Methods. Fluorescent images were overlaid on the corresponding x-ray images (i.e., a fused image). Data analysis was performed using the Kodak software. Each image was background subtracted using background x-ray and fluorescence images. Fluorescent images were evaluated using the intensity scale (included in Fig. 5 ) and quantitatively assessed to determine mean fluorescence intensity by drawing a region of interest around each bone sample.
Prussian Blue Staining
Frozen muscle sections were fixed in 10% neutral buffered formalin (Sigma-Aldrich, St. Louis, http://www.sigmaaldrich.com) followed by washing in H 2 O. Tissues were incubated for 30 minutes with 5% potassium ferrocyanide in 6% hydrochloric acid, washed, and counterstained with nuclear fast red. Images were taken using a Zeiss microscope (Carl Zeiss, Jena, Germany, http://www.zeiss.com).
Statistical Analyses
Data were expressed as mean values based upon a number of observations Ϯ SD. Statistical analysis was performed using a two-tailed Student's t test with equal variance. Values were considered significantly different at the 95% confidence level. 
RESULTS
Labeling Human Stem/Progenitor Cell Subsets
Cell Cycle, Viability, and Clonogenic Potential
To allow accurate tracking of human progenitors to the marrow and other tissue compartments in vivo, it is important to determine whether both cycling and noncycling human stem and progenitor cells sequester nanoparticles in an equivalent manner. Retroviral vectors, also used for cell marking and tracking, will only transduce cells that pass through mitosis [33] , and lentiviral vectors require metabolic activation to progress from the G0 to the G1 phase of the cell cycle prior to viral integration [34] . A method is thus needed that allows marking of quiescent cells. To evaluate nanoparticle labeling as a function of cell cycle status, CD34 ϩ cells from CB were labeled with a membrane dye (PKH26) to characterize cell proliferation over a 72-hour period. Labeled Fe [750] ϩ CD34 ϩ cells were harvested at 24-hour intervals and analyzed by flow cytometry. Gating on the emission of PKH26 shows that after 72 hours of culture, 25.8% of the cells had divided twice, 56.3% had divided once, and the remaining 16.9% of the cells had not divided (Fig. 2) . Each cell population, gated based on division history, was examined to assess the percentage of Fe [750] ϩ CD34 ϩ cells. Of the cells that had actively divided, 16.7% of the total cell population that had divided once and 12% of the cells that had divided twice were Fe [750] ϩ CD34 ϩ . Within the cell population that had not proliferated, 26.4% of cells were Fe [750] ϩ CD34
ϩ . These data demonstrate that quiescent cells can be labeled at least as efficiently as dividing cells using Fe [750] . These data emphasize an advantage for the use of nanoparticles over the use of viral transduction for short-term in vivo tracking studies, that is, the potential labeling of quiescent cells and also avoiding the risk of adverse effects that viral transduction and potential insertional integration could potentially impose on human HSC [35] .
Clonogenic progenitor assays were performed as an initial test to evaluate whether there were potential negative effects of the nanoparticle labeling on cell survival and proliferation. CB Lin Ϫ cells were incubated overnight with and without ProFe [647] . Harvest cells were plated into semisolid methylcellulose medium for assessment of clonogenic potential. The colony-forming capacities from nanoparticle-labeled and nonlabeled cells derived from the same source are summarized in Table 2 
Tracking Labeled Cells in NOD/SCID ␤2M-Null Mice
We investigated the time period after transplantation in which the labeled cells could be tracked, and we determined whether the labeling strategy imposed any adverse effects on human stem cell homing or on the subsequent hematopoietic contribution in vivo. CD34 ϩ cells were cultured overnight with Fe[647] particles, and the labeled cell population contained a total of 24% Fe [647] ϩ human CD34 ϩ cells. Labeled cells were acquired using flow cytometer-based cell sorting to remove unlabeled cells and free Fe[647] contaminants. NOD/SCID ␤2M-null mice (n ϭ 15) were then transplanted with Fe[647]-labeled human CB-derived CD34 ϩ cells. Mice transplanted with the sorted cells were sacrificed at 1, 2, and 3 weeks. The femurs and tibiae from each animal were flushed with PBS buffer, and the collected marrow cells were assessed for the percentages of Fe[647]-labeled and unlabeled human CD45-positive cells. Endpoint analyses at weeks 1 (n ϭ 4) and 2 (n ϭ 6) showed similar engraftment between total CD45 ϩ cells and CD45 ϩ cells that colabeled for nanoparticle content (Fig. 3A) . The data suggested continued accrual of labeled cells to the marrow compartment over the first 2 weeks. Cell migration from sites of nonspecific lodgment into the bone marrow over the initial 2 weeks posttransplantation has previously been reported [36] . At week 3, engraftment constituted 9.5% Ϯ 6.2% CD45 ϩ cells in the chimeric BM (n ϭ 5), with only 0.6% Ϯ 0.4% Fe [647] ϩ . By this point, the human cells had expanded sufficiently to dilute out the nanoparticle label, or the particles had been at least partially degraded [37] , but label was still observed in a small number of the human CD45 ϩ cells. These data demonstrate that there was no loss in long-term viability, marrow homing, or hematopoietic capacity of human hematopoietic stem cells caused by the labeling procedure and that the cells retained label sufficient for analysis for the initial 2 weeks post-transplantation.
Prussian blue staining was done on muscle tissue from several of the engrafted mice to visually locate hematopoietic cells that may have lodged in nonhematopoietic sites, as a first step in tracking labeled cells following bone marrow engraftment. Figure 3B shows Prussian blue staining of Feridex-labeled cells in the muscle tissue adjacent to the femur of a mouse transplanted with 5 ϫ 10 5 labeled human CD34 ϩ progenitors. To increase the sensitivity of in situ detection, we used red-shifted Fe[750] nanoparticles in subsequent assays. Figure 4 is a representative example from the transplantation experiments using Fe[750] nanoparticle-loaded cells. Figure 4A shows the forward and side scatter plot, which demonstrates the impor- Figure 5A , from the nanoparticle-low fraction, the signal in the bones was much stronger. The intensity of the spleen in this mouse was also high, indicating that a large Abbreviation: BFU-E, burst-forming unit-erythrocyte; CFU-GEMM, colony-forming unit granulocyte/erythrocyte/macrophage/ megakaryocyte; CFU-GM, colony-forming unit granulocyte/ macrophage; Pro, protamine sulfate. Figure 5B and 5F demonstrate the importance of eliminating unbound particles from the cell population to be injected. These mice were injected intrafemorally with free particles, and there was a resulting strong signal in each case. The spleen from the mouse injected i.v. with free particles was very bright (Fig. 5F ), indicating nonspecific lodgment of the nanoparticles in spleen tissue. Another control is shown in Figure 5E , where PBS alone was injected, and only minimal background autofluorescence was observed in both marrow and spleen. The samples shown in Figure 5 were all imaged on the same day, in direct comparison with one another.
In summary, the images show that mice that had received an i.v. or i.f. injection of FACS-sorted Fe [750] hi CD34 ϩ cells had higher signal in the femur and tibia, as compared with the control mice that had received PBS or Fe [750] lo CD34 ϩ cells. Free particles (as well as nonsorted bulk cultures transplanted into the mice; data not shown) displayed high signals comparable to the signal of FACS-sorted Fe [750] ϩ CD34 ϩ cells. These data demonstrate that purification of the Fe [750] ϩ CD34 ϩ population is a necessary step prior to imaging to ensure that the signal observed is due to migrating cells rather than to free nanoparticles lodging in the tissue.
DISCUSSION
Quiescent human HSC are difficult to label using viral vectors or other modalities to allow tracking in vivo. Here, we present a rapid method to label and directly monitor human cell engraftment using flow cytometry in combination with fluorescence imaging. Two commercially available agents, Feridex and protamine sulfate, formed stable complexes capable of efficiently labeling human HSC subsets. Previous studies have demonstrated that Pro-Fe labeling does not adversely affect the viability of human progenitor cells [11] . Our results extend these observations to immunodeficient mice to evaluate the repopulation capacity of nanoparticle-labeled, highly purified human cells. By conjugating fluorophore to the dextran coat of Feridex, signals generated from labeled human HSC subsets could be measured by both flow cytometry and fluorescence imaging. Traditional staining with Prussian blue for counting iron oxidelabeled cells provides little information about labeling efficiencies or cell type. Here, flow cytometry analysis allowed direct assessment of the number of labeled cells with a cell specific marker, such as CD34 in vitro or human-specific CD45 in vivo, to better define the labeled population.
The current model provides an improvement over the other, previously described systems because the fluorescent tag allows flow-based sorting of labeled cells to remove the nonlabeled cells and unbound beads, to obtain a clean population of labeled cells prior to transplantation. We are injecting a pure population into the animals. This is an improvement over other sorting methods, such as magnetic sorting, where "free" unbound particles are also captured for injection. Our data indicate that the unbound particles can confound initial interpretations because they may be sequestered in areas of damage or inflammation. These unbound particles will likely be phagocytosed by murine macrophages, but for early time points it is possible that they can mask or confuse results, so removal is optimal.
Since Feridex is biologically inactive, the primary cellular uptake mechanism of the protamine-sulfate-complexed Feridex particles may occur through endosomal capture, endocytosis [14, 38] , or membrane-mediated interaction with the Pro-Fe complex. Loading differences between human HSC from different sources might reflect differences in membrane properties or corresponding cellular activity, such as metabolic quiescence and low ATP levels. However, the current studies demonstrate that highly quiescent human hematopoietic stem/progenitor cells can be labeled with nanoparticles to efficiencies equivalent to those of dividing cells. Other reporter labeling methods, such as viral transduction, require that the cells be actively cycling [33, 34] . Interestingly, adding more Fe[750] to the cultures did not result in higher numbers of labeled CD34 ϩ cells. Furthermore, increasing the protamine sulfate concentration did not affect the loading protocol. The optimal protamine sulfate concentration observed in this study was 1 g/ml, which is in accordance with other published data [11] . At concentrations greater than 20 g/ml, an increasing number of CD34 ϩ cells became unhealthy or nonviable (data not shown).
Cohorts ϩ cells could be observed in the bone marrow of the recipient animals, but the nanoparticle label dropped by weeks 3 and 4. These data indicate that as the cells begin to divide there is a decrease in the detection of nanoparticle-labeled cells. Thus, one disadvantage of nanoparticle-labeling techniques is evident in the data, that is, dilution of the signal by cell division or cell death. It is interesting that the nanoparticle ϩ and CD45 ϩ levels both increased over the first 2 weeks postinjection, which mirrors previously published data showing continual recruitment to the marrow compartment during this period of time [36] . After injection, stem and progenitor cells lodge in the lung, spleen, and liver and then seed from those organs to the marrow space, because of higher levels of stromal-derived factor (SDF-1) produced there. SDF-1, the ligand for CXCR4 on stem/progenitor cells, is the most potent chemotactic signal for primitive stem cells. Our data recapitulate this continuing accrual to the marrow and will provide other laboratories with a method to further query these homing events. Therefore, it would appear that initially the cells are not expanding within the marrow but are migrating there. Cashman et al. have demonstrated that human cells transplanted into immune-deficient mice do not divide much in the marrow space for the first 2 weeks postinjection, but in week 3, there begins to be an expansion [39] , and our data fit with this report.
For the first time, in the current study, Fe[647]-and Fe[750]-labeled CD34 ϩ cells were FACS-sorted prior to transplantation. Purification of Feridex-labeled cells by centrifugation, filtration, or magnetic separation methods results in a contaminated target cell population. Although magnetic sorting results in the removal of unlabeled cells, free, unbound particles still remained in the cell solution. FACS analysis of bulk cultures shows that more than 75%-90% of counted events arise from free Fe [750] in solution, if the cells are not first sorted to remove the unbound particles. Removal of excess nanoparticles by FACS ensured that the population used for transplantation was more than 99% pure and that the in vivo detection was not an artifact arising from unbound particles.
The nanoparticles used in this study inherently contain T2‫ء‬ properties that allow them to be imaged by MRI as described by a number of groups [3, 4, 7, 11, 38] . Attempts to acquire MRI images of the spleen and bone marrow in live animals failed at the cell doses used in our experiment (4 ϫ 10 5 ). However, other groups have reported detecting labeled cells in the bone marrow and spleen in animals transplanted with 1 ϫ 10 7 cells [3] , and Anderson et al. detected migrated iron-labeled Sca1 ϩ cells in implanted glioma in mice using only 5 ϫ 10 5 iron-positive cells [40] . Perhaps slightly increasing our cell transplantation number or using a model such as tumor targeting, which allows a more focused migration in vivo, could result in noninvasive imaging for tracking of human stem cell subsets in vivo by MRI. When transplanting primary hematopoietic stem/progenitor cells, the engraftment is diffuse throughout many tissues.
Using the current techniques, flow cytometry analysis gating on CD34 ϩ or CD45 ϩ expression and Fe[750] confirms the presence of human cells residing in the BM. Using this method, we propose that as few as 1 ϫ 10 5 Fe[750] ϩ CD34 ϩ cells residing in the bone marrow can be detected by fluorescence imaging. Beyond 2 weeks, the human cell expansion, egress from the marrow, and iron metabolism began to dilute the nanoparticle signal below the limit of detection of both techniques. The current data demonstrate that transient labeling of repopulating HSC subsets with fluorescent nanoparticles is a powerful and novel tool for dynamic tracking of human stem cells during the initial weeks after transplantation. 
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